GW Pharma Shares Double Following Positive Epidiolex Trial

Shares of GW Pharmaceuticals PLC-ADR GWPH 1.12% are up nearly 120 percent in early Monday trading after the company announced positive Phase III data on Epidiolex. The study found that the drug significantly reduced seizures in children suffering from Dravet Syndrome, a condition for which there are currently no FDA-approved treatments.

Hedge Funds Now ‘Strongly Bullish’ On Oil

WTI crude oil prices have soared 37.6 percent in the past month, but the market remains divided on whether the oil rally is for real. Shares of the United States Oil Fund LP (ETF) USO 0.76% have only risen 28.0 percent during the past month, an indication that many investors are not convinced that the…

Researchers Link Binge Watching With Depression, Anxiety

Researchers at the University of Toledo have found a link between extended television “binge watching” and both depression and anxiety. Binge watching has become increasingly popular since Netflix, Inc. NFLX 0.96% has begun making entire new seasons of hit shows like “House of Cards” and “Orange is the New Black” available all at once.